Profusa, Inc. (PFSA)Healthcare | Medical Devices | Berkeley, United States | NasdaqCM
2.93 USD
-1.31
(-30.896%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 2.79 -0.14 (-0.140%) ⇩ (Aug. 28, 2026, 7:59 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 3:43 a.m. EDT
The immediate outlook is severely compromised by a chaotic price environment and a catastrophic balance sheet. The stock has just undergone a 1-for-75 reverse split, evidenced by the price jumping from sub-dollar levels to the mid-$30s before settling near $5.46, yet the company remains insolvent with negative book value of -$296.19 and a current ratio of merely 0.03. This indicates severe liquidity distress where liabilities vastly exceed assets. Fundamentally, the business is deteriorating rapidly, generating massive free cash flow outflows of nearly $20 million and posting a trailing EPS of -$1,117.91, signaling deep operational losses. There is no dividend support whatsoever, and the lack of any price history since the split prevents any assessment of long-term trends. While the recent volatility might suggest speculative interest, the underlying fundamentals of insolvency and bleeding cash make this a clear avoidance for any rational investor. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.721169 |
| MSTL | 0.747616 |
| AutoARIMA | 0.748367 |
| AutoTheta | 0.754283 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 12% |
| H-stat | 16.69 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 1.11 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 1,774,777 |
| Beta | 0.49 |
| Website | https://profusa.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.9985044 |
| Address1 | 626 Bancroft Way |
| Address2 | Suite A |
| All Time High | 41,250.0 |
| All Time Low | 3.224 |
| Ask | 6.9 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 6,273,597 |
| Average Daily Volume3 Month | 1,098,547 |
| Average Volume | 1,098,547 |
| Average Volume10Days | 6,273,597 |
| Beta | 0.494 |
| Bid | 3.31 |
| Bid Size | 1 |
| Book Value | -296.194 |
| City | Berkeley |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.93 |
| Current Ratio | 0.03 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 4.13 |
| Day Low | 2.74 |
| Display Name | Profusa |
| Ebitda Margins | 0.0 |
| Enterprise Value | 15,159,546 |
| Eps Trailing Twelve Months | -922.06 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 8.38266 |
| Fifty Day Average Change | -5.4526596 |
| Fifty Day Average Change Percent | -0.6504689 |
| Fifty Two Week Change Percent | -99.85044 |
| Fifty Two Week High | 4,500.0 |
| Fifty Two Week High Change | -4,497.07 |
| Fifty Two Week High Change Percent | -0.9993489 |
| Fifty Two Week Low | 2.74 |
| Fifty Two Week Low Change | 0.19000006 |
| Fifty Two Week Low Change Percent | 0.06934309 |
| Fifty Two Week Range | 2.74 - 4500.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,752,240,600,000 |
| Float Shares | 302,575 |
| Free Cashflow | -19,129,250 |
| Full Exchange Name | NasdaqCM |
| Fullday Change | -1.31 |
| Fullday Change Percent | -30.8962 |
| Fullday Price | 2.79 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.12593001 |
| Held Percent Institutions | 0.034879997 |
| Implied Shares Outstanding | 605,726 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,025-07-14 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,786,924,800 |
| Last Split Factor | 1:4 |
| Long Business Summary | Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California. |
| Long Name | Profusa, Inc. |
| Market | us_market |
| Market Cap | 1,774,777 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_141932876 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -42,970,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 2,553,135 |
| Open | 4.1 |
| Operating Cashflow | -20,330,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 925 997 6925 |
| Post Market Change | -0.1400001 |
| Post Market Change Percent | -4.7781606 |
| Post Market Price | 2.79 |
| Post Market Time | 1,787,961,597 |
| Previous Close | 4.24 |
| Price Hint | 4 |
| Price To Book | -0.009892166 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.026 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -1.31 |
| Regular Market Change Percent | -30.8962 |
| Regular Market Day High | 4.13 |
| Regular Market Day Low | 2.74 |
| Regular Market Day Range | 2.74 - 4.13 |
| Regular Market Open | 4.1 |
| Regular Market Previous Close | 4.24 |
| Regular Market Price | 2.93 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 627,168 |
| Return On Assets | -7.25255 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 605,726 |
| Shares Percent Shares Out | 0.018 |
| Shares Short | 10,879 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 13,298 |
| Short Name | Profusa, Inc. |
| Short Percent Of Float | 0.018 |
| Short Ratio | 0.08 |
| Source Interval | 15 |
| State | CA |
| Symbol | PFSA |
| Total Cash | 719,000 |
| Total Cash Per Share | 1.187 |
| Total Debt | 14,104,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -922.06 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 326.42767 |
| Two Hundred Day Average Change | -323.49768 |
| Two Hundred Day Average Change Percent | -0.9910241 |
| Type Disp | Equity |
| Volume | 627,168 |
| Website | https://profusa.com |
| Zip | 94,710 |